Publication | Open Access
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
67
Citations
21
References
2019
Year
These results suggest that NST-1s attenuates CIA progression via the inhibition of osteoclastogenesis and might be a potential therapeutic agent for RA therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1